Annual report
3762.TEDINET S100R6A5
Period2022-04-01 → 2023-03-31
Filed2023-06-27
StandardIFRS
ConsolidatedYes
Data checks21 of 22 passed
Key figures · 188
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥46.0bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥36.5bn | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥30.6bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥30.9bn | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥28.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥27.6bn | 2019-04-01 → 2020-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥25.4bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥5.1bn | 2022-04-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥3.7bn | 2021-04-01 → 2022-03-31 | Cons. | Operating profit loss IFRS |
| Ordinary income | ¥3.7bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.0bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.4bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥5.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥3.7bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥3.4bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥2.7bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥3.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥2.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥2.3bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.3bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥1.9bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥1.5bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥3.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥2.6bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥65.7bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥52.5bn | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥36.6bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥40.0bn | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥29.6bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥35.7bn | at 2020-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥25.7bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥31.2bn | at 2019-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥41.8bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥32.3bn | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥23.9bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥20.2bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥16.4bn | at 2021-03-31d | Cons. | Equity IFRS |
| Net assets / equity | ¥16.3bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥15.0bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥12.4bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Equity (owners) | ¥19.0bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥17.0bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥14.8bn | at 2021-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥13.0bn | at 2020-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥10.6bn | at 2019-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥20.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥18.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥14.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥14.2bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥13.4bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥13.7bn | at 2020-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥11.8bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥11.9bn | at 2019-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥6.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥5.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥2.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.5bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥2.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.0bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥2.0bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥3.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥196m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥911m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥841m | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥999m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥541m | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥650m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥1.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.8bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥124m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥569m | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥4.4bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥73.91 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥59.65 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥58.9 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥57.92 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥47.05 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.24 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥41.08 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥73.67 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥59.46 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥58.73 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥57.75 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥46.92 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥46.11 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥40.64 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥475.24 | at 2023-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥426.4 | at 2022-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥372.96 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥373.53 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥343.67 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥327.18 | at 2020-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥291.67 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥278.65 | at 2019-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 28.9% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 32.4% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 40.5% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.1% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 46.1% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.4% | at 2020-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 43.2% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.1% | at 2019-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 16.4% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 14.9% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 16.4% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.5% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 15.0% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.5% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 17.3% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,073 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 1,038 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 1,014 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥30.9bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥26.5bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥23.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥20.9bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥18.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.7bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥2.8bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥2.7bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.8bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.7bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.3bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.3bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.5bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥2.4bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥1.7bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥1.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.4bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥47.5bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥37.0bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥29.3bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥23.0bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥19.4bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥33.3bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥24.4bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥14.2bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥12.6bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥11.4bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥10.7bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥8.6bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥11.0bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥8.9bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥60.2 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.76 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.17 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥36.14 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.8 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥60 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.62 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥47.04 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥36.04 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥32.45 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥23 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥352.02 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥312.64 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥283.36 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥266.43 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥222.74 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 29.6% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.7% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.1% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.8% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 18.1% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.7% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.0% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.6% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 44,518,400 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 44,518,400 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 44,518,400 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 22,259,200 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 22,259,200 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 544 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 511 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 475 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 429 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 405 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥458m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥458m |
| Application Servicereportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥7.5bn |
| Application Servicereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥7.3bn |
| Application Servicereportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥174m |
| Application Servicereportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥21m |
| Information Infrastructurereportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥29.6bn |
| Information Infrastructurereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥29.3bn |
| Information Infrastructurereportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥282m |
| Information Infrastructurereportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥3.1bn |
| Medical System Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥9.3bn |
| Medical System Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥9.3bn |
| Medical System Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥2m |
| Medical System Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥46.4bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥46.0bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥458m |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥5.1bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥346m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥346m |
| Application Servicereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥7.3bn |
| Application Servicereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥7.2bn |
| Application Servicereportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥78m |
| Application Servicereportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥49m |
| Information Infrastructurereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥25.0bn |
| Information Infrastructurereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥24.7bn |
| Information Infrastructurereportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥240m |
| Information Infrastructurereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥3.1bn |
| Medical System Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥4.6bn |
| Medical System Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.6bn |
| Medical System Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥28m |
| Medical System Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥728m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥36.9bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥36.5bn |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥346m |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥3.7bn |
| Application Servicereportable segment | employees | at 2023-03-31 | 277 pure |
| Information Infrastructurereportable segment | employees | at 2023-03-31 | 215 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,775
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of employees | Prior1YearInstant_NonConsolidatedMember | 511 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 544 | |
| Average number of temporary workers | Prior4YearInstant_NonConsolidatedMember | 67 | |
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | 69 | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 69 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 74 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 74 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 0.062 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.282 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 1.280 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 1.497 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 0.782 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | -0.073 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | -0.183 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 0.138 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 0.134 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 0.167 | |
| Number of employees IFRS (5-year summary) | CurrentYearInstant_jpcrp030000-asr_E05463-000InformationInfrastructureReportableSegmentMember | 613 | |
| Average number of temporary workers IFRS (5-year summary) | CurrentYearInstant_jpcrp030000-asr_E05463-000InformationInfrastructureReportableSegmentMember | 48 | |
| Number of employees IFRS (5-year summary) | CurrentYearInstant_jpcrp030000-asr_E05463-000ApplicationServiceReportableSegmentMember | 360 | |
| Average number of temporary workers IFRS (5-year summary) | CurrentYearInstant_jpcrp030000-asr_E05463-000ApplicationServiceReportableSegmentMember | 35 | |
| Number of employees IFRS (5-year summary) | CurrentYearInstant_jpcrp030000-asr_E05463-000MedicalSystemBusinessReportableSegmentMember | 414 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E05463-000MedicalSystemBusinessReportableSegmentMember | 42 | |
| Number of employees IFRS (5-year summary) | CurrentYearInstant_CorporateSharedMember | 52 | |
| Average number of temporary workers IFRS (5-year summary) | CurrentYearInstant_CorporateSharedMember | 13 | |
| Number of employees IFRS (5-year summary) | CurrentYearInstant | 1439 | |
| Average number of temporary workers IFRS (5-year summary) | CurrentYearInstant | 138 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 544 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 74 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 37.8 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 8.3 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 7866000 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05463-000InformationInfrastructureReportableSegmentMember | 215 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05463-000InformationInfrastructureReportableSegmentMember | 37 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05463-000ApplicationServiceReportableSegmentMember | 277 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05463-000ApplicationServiceReportableSegmentMember | 21 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 52 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 16 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 544 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 74 | |
| Research and development expenses research and development activities | CurrentYearDuration | 45179000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 5470216000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E05463-000InformationInfrastructureReportableSegmentMember | 567378000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E05463-000ApplicationServiceReportableSegmentMember | 712706000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E05463-000MedicalSystemBusinessReportableSegmentMember | 2002339000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_OtherReportableSegmentsMember | 2187792000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 44518400 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 44518400 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 44518400 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 44518400 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 22 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | mismatch |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |